IXICO PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IXICO PLC with three other
companies in this sector in UNITED KINGDOM :
sales of £10.31 million [US$14.17 million]
Redx Pharma PLC
(£5.69 million [US$7.81 million]
Reneuron Group PLC
(£6.07 million [US$8.33 million]
of which 100%
was Development of cell-based therapies).
IXICO PLC reported sales of £9.53 million (US$13.09 million)
September of 2020.
increase of 26.1%
versus 2019, when the company's sales were £7.56 million.
This was the fourth straight year of sales growth at IXICO PLC.